Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study.

Subjects

Subjects :

*COVID-19 vaccines
*CANCER patients
*TREATMENT effectiveness
*IMMUNE response
*SCIENTIFIC observation

Details

Language :

English

ISSN :

09237534

Volume :

33

Issue :

7

Database :

Academic Search Index

Journal :

Annals of Oncology

Publication Type :

Academic Journal

Accession number :

157421604

Full Text :

https://doi.org/10.1016/j.annonc.2022.04.002